Evidence map›Paper›PMID 34073079›Full record

ReviewInternational journal of molecular sciences2021

Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma.

Hui Xie, Felix K-H Chun, Jochen Rutz, Roman A Blaheta

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Therapeutic Effects of Sulforaphane onInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. International journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Bladder cancer, inflammageing and microbiomes.Nature reviews. Urology · 2022
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hui XieDepartment of Urology, Goethe-University, 60590 Frankfurt am Main, Germany.
Felix K-H ChunDepartment of Urology, Goethe-University, 60590 Frankfurt am Main, Germany.
Jochen RutzDepartment of Urology, Goethe-University, 60590 Frankfurt am Main, Germany.
Roman A BlahetaDepartment of Urology, Goethe-University, 60590 Frankfurt am Main, Germany.ORCID 0000-0002-0129-7972
Goethe University Frankfurt · DE

Funding

Brigitta & Norbert Muth Stiftung, Wiesbaden, Germany N/AChina Scholarship Council 201707660003
6 · The paper itself

Abstract

Sulforaphane (SFN) is a natural glucosinolate found in cruciferous vegetables that acts as a chemopreventive agent, but its mechanism of action is not clear. Due to antioxidative mechanisms being thought central in preventing cancer progression, SFN could play a role in oxidative processes. Since redox imbalance with increased levels of reactive oxygen species (ROS) is involved in the initiation and progression of bladder cancer, this mechanism might be involved when chemoresistance occurs. This review summarizes current understanding regarding the influence of SFN on ROS and ROS-related pathways and appraises a possible role of SFN in bladder cancer treatment.

Indexed as

Anticarcinogenic AgentsAntioxidantsIsothiocyanatesSulfoxidesAnimalsCarcinomaCell Line, TumorHumansKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Reactive Oxygen SpeciesUrinary Bladder NeoplasmsAnticarcinogenic AgentsAntioxidantsIsothiocyanatesKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen SpeciessulforaphaneSulfoxidesbladder cancerKeap1-Nrf2oxidative stressROSsulforaphane

Identifiers

PMID34073079
PMCPMC8197880
OpenAlexW3164075543

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.